GlassScriptPhysician profile
Kelsie White
NPI 1780270033
$1,952.86
in general payments reported to CMS, 2019-2025
16 companies · $49.77 in 2025
The $49.77 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.96 · 2022: $17.26 · 2023: $1,382 · 2024: $479 · 2025: $49.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645 · Education: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.15 |
| Education | $265.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $559.87 | 2023-2024 | Corevalve Evolut R, Linq II |
| Novartis Pharmaceuticals Corporation | $284.42 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $216.53 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $150.13 | 2023-2024 | Brilinta, Wainua, Farxiga |
| Abiomed | $131.55 | 2023 | Impella |
| Edwards Lifesciences Corporation | $131.26 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $91.71 | 2022-2024 | Verquvo, Belsomra |
| Lexicon Pharmaceuticals, INC. | $83.90 | 2023 | Inpefa |
| Impulse Dynamics (USA) INC. | $80.69 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $72.53 | 2023 | Arcalyst |
| Pfizer INC. | $53.59 | 2023-2024 | |
| Hologic Sales and Service, LLC | $24.96 | 2021 | |
| Shockwave Medical, INC | $20.90 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $18.26 | 2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $17.22 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.34 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsie White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.